Dariusz Goźliński

"First, do no harm!"- This should be, the first rule for the communication activities in the field of pharmaceutical and legal.

Who am I?
Passionate about marketing and advertising. Strongly associated with the pharmaceutical industry and related. I create and I manage advertising campaigns including the use of social media in activities dedicated to doctors and patients. Professionally, I am the founder and managing director of the agency GreyTree. From 2002 r. I am associated with a limited marketing and advertising law. Among other things, worked with companies such as: Unilever, Jelfa, Sanitas Group, Adamed Healthcare, Blue Farma, Chance, Genexo, GAL, Heel Poland, Symphar, Sun Farm, Admiral, Ipsen, HiPP, Alpen Pharma or Krewel Meuselbach.

Yours,
Dariusz Goźliński
such. +48 22 628 53 61
e-mail: d.gozlinski(at)greytree.co

social media

Statements will save lives ...

9 June 2010
Statements will save lives ...

Coming to an end a nationwide campaign, promoting schools declaration of intent and knowledge of transplantation. Campaign, bearing the name of "Second Life", This action, the aim of which is to increase public awareness of organ transplantation, as a method of saving lives and restoring health seriously ill ... Read more ...

Marketing szeptany

16 April 2010
Marketing szeptany

Buzz marketing is increasingly popular form of promotion. Marketers involved in advertising campaigns are designed to give potential consumers a reason to talk about the brand and make, satisfied customers that they will recommend the product. This statement seems to be trivial, ... Read more ...

Pharmaceutical Marketing - OTC drugs

9 March 2010
Pharmaceutical Marketing - OTC drugs

OTC pharmaceutical marketing is gaining wider use. Increasing competition leads companies to implement promotional instruments and continuously improve its offer in relation to the offer competitors. It sounds like the kind of "law of the jungle" and so it is, in fact,, After all, the desire ... Read more ...

Automatic translation:

Newsletter

Twitter